Have you seen the latest news and insights on Cystic Fibrosis News Today?

Cystic Fibrosis Weekly Update Contents: Encala Improves Fat Absorption in CF Patients With Pancreatic Insufficiency, Study Shows Microbion Awarded $17M to Advance Inhaled Antimicrobial Pravibismane for Lung Infections Encala Improves Fat Absorption in CF Patients With Pancreatic Insufficiency, Study Shows Jun 05, 2020 07:00 am | David Melamed, PhD Investigational treatment Encala (Lym-X-Sorb) is safe, well tolerated, and increased dietary fat absorption in patients with cystic fibrosis (CF) and pancreatic insufficiency, according to an analysis from a Phase 2 clinical trial. Findings from the analysis were reported in the study, “Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a […] The post Encala Improves Fat Absorption in CF Patients With Pancreatic Insufficiency, Study Shows appeared first on Cystic Fibrosis News Today. Read More Microbion Awarded $17M to Advance Inhaled Antimicrobial Pravibismane for Lung Infections Jun 04, 2020 07:00 am | Ines Martins, PhD Microbion has been awarded up to $17.1 million from the nonprofit CARB-X and the Cystic Fibrosis Foundation to complete preclinical and Phase 1 clinical studies of its inhaled antimicrobial medication pravibismane for treating cystic fibrosis (CF) patients with lung infections. CARB-X — Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator — is a global partnership launched in 2016 […] The post Microbion Awarded $17M to Advance Inhaled Antimicrobial Pravibismane for Lung Infections appeared first on Cystic Fibrosis News Today. Read More Recent News Georgia College Student Receives AffloVest from Legacy Project CF Registry in UK Collecting Data on COVID-19 Infections Why My Service Dog Is Staying Home Pravibismane Receives FDA Orphan Drug Status for Treatment of CF Lung Infections COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say